Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis Inhibitors

BACKGROUND: Breast cancers are heterogeneous with variable clinical courses and treatment responses. OBJECTIVE: We sought to evaluate dynamic changes in the molecular landscape of HER2-negative tumors treated with chemotherapy and anti-angiogenic agents. PATIENTS AND METHODS: Newly diagnosed HER2-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Choo, Joan R. E., Jan, Yi-Hua, Ow, Samuel G. W., Wong, Andrea, Lee, Matilda Xinwei, Ngoi, Natalie, Yadav, Kritika, Lim, Joline S. J., Lim, Siew Eng, Chan, Ching Wan, Hartman, Mikael, Tang, Siau Wei, Goh, Boon Cher, Tan, Hon Lyn, Chong, Wan Qin, Yvonne, Ang Li En, Chan, Gloria H. J., Chen, Shu-Jen, Tan, Kien Thiam, Lee, Soo Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217774/
https://www.ncbi.nlm.nih.gov/pubmed/35699834
http://dx.doi.org/10.1007/s11523-022-00886-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217774/
https://www.ncbi.nlm.nih.gov/pubmed/35699834
http://dx.doi.org/10.1007/s11523-022-00886-x

Ejemplares similares